Top compounds associated with response to RP11-111K18.1


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.3
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.054 0.3
mRNA MI-2 CTRPv2 pan-cancer AAC -0.053 0.3
mRNA CIL70 CTRPv2 pan-cancer AAC 0.048 0.3
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.044 0.3
mRNA AT7867 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA BMS-270394 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA AT13387 CTRPv2 pan-cancer AAC 0.045 0.3
Download CSV